David Heilman

David Heilman, MS/MBA, has extensive experience in the pharmaceutical industry, spanning over multiple roles and companies. Currently, they hold the position of Director of Pharmaceutical Development & CMC at Nicox, where they lead pharmaceutical development activities and manages the clinical supply chain for phase 3 clinical studies.

Prior to Nicox, David served as Associate Director - CMC at Rockwell Medical, Inc., where they were responsible for CMC-related operations across the Ferric Pyrophosphate Citrate product portfolio. David also managed drug substance and drug product development activities, including the selection and management of Contract Manufacturing Organizations.

David's previous roles include Manager, Analytical and Formulation Resources at Catalent Pharma Solutions, where they led a biophysical characterization group and sterile product development group. David also held positions as Principal Scientist/Project Director and Senior Scientist/Project Director, where they led formulation and analytical development projects.

Before joining Catalent, David worked at ENCO Pharmaceutical Development, Inc. as Manager of Formulation Development. David also gained experience at Eisai as a Senior Principal Researcher, focusing on parenteral dosage formulation techniques and topical dosage forms.

Additionally, David has a distinguished military career, retiring as a Major in the US Army Corps of Engineers after 23 years of service. David served in positions that required strategic and tactical planning, project management, and operations and supply chain expertise.

David started their pharmaceutical career at Trimeris, Inc. as a Senior Scientist in Pharmaceutical Development, developing macromolecule formulations for parenteral delivery. David also worked as an Analytical Chemist at Mylan Pharmaceuticals, Inc., gaining experience in both QC and R&D environments.

Throughout their career, David has demonstrated strong leadership skills and experience in various aspects of pharmaceutical development, CMC operations, and supply chain management.

David Heilman, MS/MBA, completed their Master of Business Administration (MBA) in Strategy and Leadership from the University of North Carolina at Chapel Hill from 2017 to 2019. Prior to that, they pursued a Master of Science (MS) in Chemistry at Ohio University from 1990 to 1993, and obtained a Bachelor of Science (BS) in Chemistry and Mathematics from Wheeling University from 1988 to 1990. David also has a background in Chemistry and Mathematics from West Liberty University during the period of 1985 to 1987. Additionally, David obtained a certification in Inclusive Leadership from LinkedIn in 2020.